Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:30 PM - 3:40 PM ET

213 - Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report
Speaker: Gui, Bin, MD, MS - UNC Health, Chapel Hill, NC
3:30 PM - 3:40 PM ET

218 - CDCP1-Directed <sup>89</sup>Zr/<sup>177</sup>Lu Radiotheranostics for Radioresistant Non-Small Cell Lung Cancer
Speaker: Liu, Jie, MD, PhD - Shandong Cancer Hospital and Institute, Jinan, Shandong
3:30 PM - 3:40 PM ET

224 - Event-Free Survival after Definitive Radiotherapy vs. Upfront Surgery for Axillary and Inguinal Nodal Merkel Cell Carcinoma: A Population-Based Retrospective Analysis
Speaker: Stoker, Daniel, MD - Princess Alexandra Hospital, Woolloongabba, QLD
3:30 PM - 3:35 PM ET

3258 - Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Pelvic Reirradiation: A Phase 1/2 Trial
Speaker: Droznin, Alexander - Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston, MA
3:35 PM - 3:55 PM ET

Questions & Answers
Speaker: Yang, Jonathan, MD, PhD - New York University School of Medicine, New York, NY
3:35 PM - 3:50 PM ET

Questions & Answers
Speaker: Valle, Luca, MD - UCLA Radiation Oncology, Los Angeles, CA
3:35 PM - 3:55 PM ET

Questions & Answers
Speaker: Shen, Colette, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
3:35 PM - 3:55 PM ET

Questions and Answers
Speaker: Price, Michael, PhD, MS, DABR FAAPM - Columbia University Irving Medical Center, New York, NY
3:40 PM - 3:50 PM ET

1199 - Non-Surgical Management of Merkel Cell Carcinoma with Definitive Radiation Therapy
Speaker: Fattahi, Sayeh, MD - Harvard Radiation Oncology Program, Boston, MA
3:40 PM - 3:50 PM ET

214 - Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) Targeting the Cervical Primary in Stage IVB Cervical Cancer: Results of a Phase I Trial
Speaker: Albuquerque, Kevin, MD - Simmons Comprehensive Cancer Center, UTSW Radiation Oncology, Dallas, Texas
3:40 PM - 3:50 PM ET

219 - Lineage Tracing to Characterize Response to Radiation and Immunotherapy in Breast Cancer
Speaker: Marshall, Abigail, PhD, BS - Geisel School of Medicine at Dartmouth, Lebanon, WA
3:50 PM - 4:00 PM ET

220 - CRISPR Screening Identifies PCCB as a Mitochondrial Driver of Radioresistance via Stabilizing Mitochondrial Homeostasis
Speaker: Sun, Yajie, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei